|
Volumn 46, Issue 6, 1996, Pages 1674-1677
|
Prognostic significance of 111Indium-DTPA CSF flow studies in leptomeningeal metastases
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTARABINE;
METHOTREXATE;
PENTETATE INDIUM IN 111;
THIOTEPA;
ANTINEOPLASTIC AGENT;
DIAGNOSTIC AGENT;
INDIUM;
PENTETIC ACID;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BLOOD CEREBROSPINAL FLUID BARRIER;
BRAIN METASTASIS;
CANCER SURVIVAL;
CAUSE OF DEATH;
CHILD;
CLINICAL ARTICLE;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMAGE ENHANCEMENT;
INTRATUMORAL DRUG ADMINISTRATION;
LEPTOMENINX;
MALE;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
RADIOISOTOPE VENTRICULOGRAPHY;
SURVIVAL RATE;
BRAIN VENTRICULOGRAPHY;
CEREBROSPINAL FLUID;
COMPARATIVE STUDY;
FLOW KINETICS;
HYDROCEPHALUS;
INTRACEREBROVENTRICULAR DRUG ADMINISTRATION;
LIFE TABLE;
MENINGIOMA;
METASTASIS;
MIDDLE AGED;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
SCINTISCANNING;
SKULL IRRADIATION;
SURVIVAL;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAUSE OF DEATH;
CEREBRAL VENTRICULOGRAPHY;
CHILD;
COMBINED MODALITY THERAPY;
CRANIAL IRRADIATION;
CYTARABINE;
FEMALE;
HUMANS;
HYDROCEPHALUS;
INDIUM RADIOISOTOPES;
INJECTIONS, INTRAVENTRICULAR;
LIFE TABLES;
MALE;
MENINGEAL NEOPLASMS;
METHOTREXATE;
MIDDLE AGED;
PENTETIC ACID;
PROGNOSIS;
RHEOLOGY;
SURVIVAL ANALYSIS;
THIOTEPA;
TREATMENT OUTCOME;
|
EID: 0029665513
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/WNL.46.6.1674 Document Type: Article |
Times cited : (131)
|
References (11)
|